Precigen (PGEN) Liabilities and Shareholders Equity (2016 - 2025)

Precigen (PGEN) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $155.5 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 7.05% to $155.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $557.5 million through Dec 2025, up 27.64% year-over-year, with the annual reading at $155.5 million for FY2025, 7.05% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $155.5 million at Precigen, down from $171.3 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $407.0 million in Q1 2021, with the low at $73.2 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $223.2 million, with a median of $199.1 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity plummeted 64.75% in 2024, then skyrocketed 105.17% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $359.9 million in 2021, then tumbled by 39.98% to $216.0 million in 2022, then plummeted by 30.07% to $151.0 million in 2023, then decreased by 3.82% to $145.3 million in 2024, then rose by 7.05% to $155.5 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $155.5 million, $171.3 million, and $101.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.